Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 58, Issue , 2015, Pages 22-31

  Marinho, Eduardo A V ^a   Oliveira Lima, Alexandre J ^a   Santos, Renan ^b   Hollais, André W ^b   Baldaia, Marilia A ^b   Wuo Silva, Raphael ^b   Yokoyama, Thais S ^b   Takatsu Coleman, André L ^b   Patti, Camilla L ^b   Longo, Beatriz M ^b   Berro, Laís F ^b   Frussa Filho, Roberto ^b  

^a DEPARTAMENTO DE CIÊNCIAS BIOLÓGICAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Behavioral sensitization; Cocaine; Ethanol; Morphine; Rimonabant

Indexed keywords

ALCOHOL; CANNABINOID 1 RECEPTOR; COCAINE; ENDOCANNABINOID; MORPHINE; RIMONABANT; CANNABINOID RECEPTOR ANTAGONIST; CENTRAL DEPRESSANT AGENT; DOPAMINE UPTAKE INHIBITOR; NARCOTIC AGENT; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ALCOHOL ABUSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIORAL SENSITIZATION; COCAINE DEPENDENCE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG EFFECT; EXPERIMENTAL HYPERACTIVITY; FORCED SWIM TEST; LOCOMOTION; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; OPEN FIELD TEST; SENSITIZATION; AKATHISIA, DRUG-INDUCED; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; OUTBRED STRAIN; PHYSIOLOGY; SUBSTANCE-RELATED DISORDERS;

AKATHISIA, DRUG-INDUCED; ANIMALS; ANIMALS, OUTBRED STRAINS; ANXIETY; CANNABINOID RECEPTOR ANTAGONISTS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COCAINE; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MICE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SUBSTANCE-RELATED DISORDERS;

EID: 84919346570     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.11.010     Document Type: Article

References (85)

1. Ahmed S.H., Cador M. Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology 2006, 31:563-571.
2. Akhisaroglu M., Ahmed R., Kurtuncu M., Manev H., Uz T. Diurnal rhythms in cocaine sensitization and in Period1 levels are common across rodent species. Pharmacol Biochem Behav 2004, 79:37-42.
3. Basavarajappa B.S., Ninan I., Arancio O. Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 2008, 107:1001-1013.
4. Berro L.F., Hollais A.W., Patti C.L., Fukushiro D.F., Mári-Kawamoto E., Talhati F., et al. Sleep deprivation impairs the extinction of cocaine-induced environmental conditioning in mice. Pharmacol Biochem Behav 2014, 124C:13-18.
5. Bloise E., Carey R.J., Carrera M.P. Behavioral sensitization produced by a single administration of apomorphine: implications for the role of Pavlovian conditioning in the mediation of context-specific sensitization. Pharmacol Biochem Behav 2007, 86:449-457.
6. Bocklisch C., Pascoli V., Wong J.C., House D.R., Yvon C., de Roo M., et al. Cocaine disinhibits dopamine neurons by potentiation of GABA transmission in the ventral tegmental area. Science 2013, 341:1521-1525.
7. Boyson C.O., Holly E.N., Shimamoto A., Albrechet-Souza L., Weiner L.A., DeBold J.F., et al. Social stress and CRF-dopamine interactions in the VTA: role in long-term escalation of cocaine self-administration. J Neurosci 2014, 34:6659-6667.
8. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 2000, 20:3864-3873.
9. Ceccarini J., Casteels C., Koole M., Bormans G., Van Laere K. Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study. Eur J Nucl Med Mol Imaging 2013, 40:1582-1594.
10. Centonze D., Battista N., Rossi S., Mercuri N.B., Finazzi-Agrò A., Bernardi G., et al. A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission. Neuropsychopharmacology 2004, 29:1488-1497.
11. Cheer J.F., Wassum K.M., Sombers L.A., Heien M.L., Ariansen J.L., Aragona B.J., et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 2007, 27:791-795.
12. Chinen C.C., Frussa-Filho R. Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice. Neuropsychopharmacology 1999, 21:670-678.
13. Chinen C.C., Faria R.R., Frussa-Filho R. Characterization of the rapid-onset type of behavioral sensitization to amphetamine in mice: role of drug-environment conditioning. Neuropsychopharmacology 2006, 31:151-159.
14. Corbille A.G., Valjent E., Marsicano G., Ledent C., Lutz B., Herve D., et al. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants. J Neurosci 2007, 27:6937-6947.
15. Costa F.G., Frussa-Filho R., Canteras N.S., Valera A.G., Felicio L.F. Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability. Neuropeptides 2007, 41:83-91.
16. de Araujo N.P., Fukushiro D.F., Grassl C., Hipolide D.C., Souza-Formigoni M.L., Tufik S., et al. Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle. Physiol Behav 2009, 96:12-17.
17. De Vries T.J., Schoffelmeer A.N. Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol Sci 2005, 26:420-426.
18. De Vries T.J., Cools A.R., Shippenberg T.S. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport 1998, 9:1763-1768.
19. De Vries T.J., Shaham Y., Homberg J.R., Crombag H., Schuurman K., Dieben J., et al. A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 2001, 7:1151-1154.
20. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 1988, 85:5274-5278.
21. Didone V., Quoilin C., Tirelli E., Quertemont E. Parametric analysis of the development and expression of ethanol-induced behavioral sensitization in female Swiss mice: effects of dose, injection schedule, and test context. Psychopharmacology (Berl) 2008, 201:249-260.
22. Di Marzo V. Endocannabinoids: synthesis and degradation. Rev Physiol Biochem Pharmacol 2008, 160:1-24.
23. Dyr W., Ligieza J., Kostowski W. The effect of cannabinoid CB(1) receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol 2008, 42:509-512.
24. Economidou D., Mattioli L., Cifani C., Perfumi M., Massi M., Cuomo V., et al. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology (Berl) 2006, 183:394-403.
25. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J Neurosci 1988, 8:100-112.
26. Ellinwood E.H., King G.R., Davidson C., Lee T.H. The dopamine D2/D3 antagonist DS121 potentiates the effect of cocaine on locomotion and reduces tolerance in cocaine tolerant rats. Behav Brain Res 2000, 116:169-175.
27. Fields H.L., Hjelmstad G.O., Margolis E.B., Nicola S.M. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 2007, 30:289-316.
28. Filip M., Golda A., Zaniewska M., McCreary A.C., Nowak E., Kolasiewicz W., et al. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine. Pharmacol Rep 2006, 58:806-819.
29. Frussa-Filho R., Goncalves M.T., Andersen M.L., de Araujo N.P., Chinen C.C., Tufik S. Paradoxical sleep deprivation potentiates amphetamine-induced behavioural sensitization by increasing its conditioned component. Brain Res 2004, 1003:188-193.
30. Fukushiro D.F., Carvalho Rde C., Ricardo V.P., Alvarez Jdo N., Ribeiro L.T., Frussa-Filho R. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice. Brain Res Bull 2008, 77:124-128.
31. Fukushiro D.F., Benetti L.F., Josino F.S., Oliveira G.P., Fernandes M., Saito L.P., et al. Environmental novelty and illumination modify ethanol-induced open-field behavioral effects in mice. Pharmacol Biochem Behav 2010, 95:13-22.
32. Fukushiro D.F., Josino F.S., Saito L.P., Berro L.F., Morgado F., Frussa-Filho R. Acute and chronic ethanol differentially modify the emotional significance of a novel environment: implications for addiction. Int J Neuropsychopharmacol 2012, 15:1109-1120.
33. Fukushiro D.F., Saito L.P., Mari-Kawamoto E., Aramini T.C., Costa J.M., Josino F.S., et al. Withdrawal from repeated treatment with ethanol induces a protracted decrease in novelty-seeking behavior and enhancement of environmental habituation in mice. Pharmacol Biochem Behav 2012, 101:132-137.
34. Gardner E.L. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol Biochem Behav 2005, 81:263-284.
35. Gaytan O., Lewis C., Swann A., Dafny N. Diurnal differences in amphetamine sensitization. Eur J Pharmacol 1999, 374:1-9.
36. Gerdeman G.L., Schechter J.B., French E.D. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant. Neuropsychopharmacology 2008, 33:2747-2759.
37. Gessa G.L., Muntoni F., Collu M., Vargiu L., Mereu G. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 1985, 348:201-203.
38. Gonsiorek W., Lunn C., Fan X., Narula S., Lundell D., Hipkin R.W. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Mol Pharmacol 2000, 57:1045-1050.
39. Harris G.C., Wimmer M., Byrne R., Aston-Jones G. Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine. Neuroscience 2004, 129:841-847.
40. Henry D.J., White F.J. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 1991, 258:882-890.
41. Hollais A.W., Patti C.L., Zanin K.A., Fukushiro D.F., Berro L.F., Carvalho R.C., et al. Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice. Clin Exp Pharmacol Physiol 2014, 41:255-263.
42. Humphries M.D., Prescott T.J. The ventral basal ganglia, a selection mechanism at the crossroads of space, strategy, and reward. Prog Neurobiol 2010, 90:385-417.
43. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 2006, 29:565-598.
44. Izquierdo I., Perry M.L., Dias R.D., Souza D.O., Elizabetsky E., Carrasco M.A., et al. Endogenous opioids memory modulation and state dependency. Endogenous peptides and learning and memory process 1981, 269-290. Academic, New York. J.L. Martinez, R.A. Jensen, R.B. Messing, H. Rigter, J.L. McGaugh (Eds.).
45. Justinova Z., Panlilio L.V., Goldberg S.R. Drug addiction. Curr Top Behav Neurosci 2009, 1:309-346.
46. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 1991, 16:223-244.
47. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci 1989, 45:599-606.
48. Kessler R.C., Crum R.M., Warner L.A., Nelson C.B., Schulenberg J., Anthony J.C. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997, 54:313-321.
49. Kupferschmidt D.A., Klas P.G., Erb S. Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization. Br J Pharmacol 2012, 167:196-206.
50. Kushner M.G., Sher K.J., Beitman B.D. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry 1990, 147:685-695.
51. Lupica C.R., Riegel A.C. Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction. Neuropharmacology 2005, 48:1105-1116.
52. Lupica C.R., Riegel A.C., Hoffman A.F. Marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol 2004, 143:227-234.
53. Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol 2006, 46:101-122.
54. Maldonado R., Valverde O., Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 2006, 29:225-232.
55. Marinho E.A., Oliveira-Lima A.J., Wuo-Silva R., Santos R., Baldaia M.A., Hollais A.W., et al. Selective action of an atypical neuroleptic on the mechanisms related to the development of cocaine addiction: a pre-clinical behavioural study. Int J Neuropsychopharmacol 2014, 17:613-623.
56. Masur J., Oliveira de Souza M.L., Zwicker A.P. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav 1986, 24:1225-1228.
57. Matsui A., Jarvie B.C., Robinson B.G., Hentges S.T., Williams J.T. Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal. Neuron 2014, 82:1346-1356.
58. Melis M., Pistis M., Perra S., Muntoni A.L., Pillolla G., Gessa G.L. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 2004, 24:53-62.
59. Melis M., Perra S., Muntoni A.L., Pillolla G., Lutz B., Marsicano G., et al. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. J Neurosci 2004, 24:10707-10715.
60. Mereu M., Tronci V., Chun L.E., Thomas A.M., Green J.L., Katz J.L., et al. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice. Addict Biol 2013, [in press].
61. Moreira F.A., Crippa J.A. The psychiatric side-effects of rimonabant. Rev Bras Psiquiatr 2009, 31:145-153.
62. Moreira F.A., Grieb M., Lutz B. Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. Best Pract Res Clin Endocrinol Metab 2009, 23:133-144.
63. Oleson E.B., Cheer J.F. A brain on cannabinoids: the role of dopamine release in reward seeking. Cold Spring Harb Perspect Med 2012, 2(8).
64. Oleson E.B., Beckert M.V., Morra J.T., Lansink C.S., Cachope R., Abdullah R.A., et al. Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. Neuron 2012, 73:360-373.
65. Palomino A., Pavón F.J., Blanco-Calvo E., Serrano A., Arrabal S., Rivera P., et al. Effects of acute versus repeated cocaine exposure on the expression of endocannabinoid signaling-related proteins in the mouse cerebellum. Front Integr Neurosci 2014, 8:22.
66. Pan B., Hillard C.J., Liu Q.S. D2 dopamine receptor activation facilitates endocannabinoid-mediated long-term synaptic depression of GABAergic synaptic transmission in midbrain dopamine neurons via cAMP-protein kinase A signaling. J Neurosci 2008, 28:14018-14030.
67. Piazza P.V., Deminiere J.M., le Moal M., Simon H. Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 1990, 514:22-26.
68. Powers M.S., Barrenha G.D., Mlinac N.S., Barker E.L., Chester J.A. Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference. Psychopharmacology (Berl) 2010, 212:571-583.
69. Procopio-Souza R., Fukushiro D.F., Trombin T.F., Wuo-Silva R., Zanlorenci L.H., Lima A.J., et al. Effects of group exposure on single injection-induced behavioral sensitization to drugs of abuse in mice. Drug Alcohol Depend 2011, 118:349-359.
70. Ramiro-Fuentes S., Fernandez-Espejo E. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors. Psychopharmacology (Berl) 2011, 214:949-959.
71. Riegel A.C., Lupica C.R. Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area. J Neurosci 2004, 24:11070-11078.
72. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 1986, 396:157-198.
73. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
74. Sanday L., Patti C.L., Zanin K.A., Fernandes-Santos L., Oliveira L.C., Kameda S.R., et al. Ethanol-induced memory impairment in a discriminative avoidance task is state-dependent. Alcohol Clin Exp Res 2013, 37:E30-E39.
75. Singh M.E., Verty A.N., McGregor I.S., Mallet P.E. A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine. Brain Res 2004, 1026:244-253.
76. Steketee J.D., Kalivas P.W. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol Rev 2011, 63:348-365.
77. Szabo B., Siemes S., Wallmichrath I. Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 2002, 15:2057-2061.
78. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
79. Valjent E., Bertran-Gonzalez J., Aubier B., Greengard P., Herve D., Girault J.A. Mechanisms of locomotor sensitization to drugs of abuse in a two-injection protocol. Neuropsychopharmacology 2010, 35:401-415.
80. Vanderschuren L.J., De Vries T.J., Wardeh G., Hogenboom F.A., Schoffelmeer A.N. A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci 2001, 14:1533-1538.
81. Viganò D., Valenti M., Cascio M.G., Di Marzo V., Parolaro D., Rubino T. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur J Neurosci 2004, 20:1849-1857.
82. Wang H., Lupica C.R. Release of endogenous cannabinoids from ventral tegmental area dopamine neurons and the modulation of synaptic processes. Prog Neuropsychopharmacol Biol Psychiatry 2014, 52:24-27.
83. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol Rev 1987, 94:469-492.
84. Wolf M.E., White F.J., Hu X.T. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 1994, 14:1735-1745.
85. Zarrindast M.R., Sarahroodi S., Arzi A., Khodayar M.J., Taheri-Shalmani S., Rezayof A. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav Pharmacol 2008, 19:716-723.